Washington, DC 8/24/15—Life science technology company RainDance Technologies has withdrawn its SEC registration statement for an IPO, citing market conditions. The company, which provides digital PCR and NGS sample preparation technologies, filed to go public earlier this year (see IBO 3/15/15).
Franklin Lakes, NJ 8/25/15—BD Life Sciences, part of Becton, Dickinson, has acquired Cellular Research for an undisclosed amount. Cellular Research develops products for massively parallel single-cell genetic analysis. Its Molecular Indexing technology measures gene expression profiles in single cells. “The acquisition of Cellular Research, combined with our existing cell sorting technology, will provide our customers […]
Pleasanton, CA 8/24/15; Cambridgeshire, UK 8/24/15—Roche has definitively agreed to acquire from Lumora products associated with Heat Elution technology for nucleic acid purification of multiple sample types, including FFPE tumor samples. According to Roche, Lumora’s technology simplifies nucleic acid isolation, takes only minutes and can be used with a variety of samples types. “Lumora’s Heat […]
Basel, Switzerland 8/19/15—Roche has agreed to acquire Kapa Biosystems for an undisclosed amount. US-based Kapa provides life science reagents for NGS and real-time PCR applications, including enzymes such as novel DNA polymerases. Roche stated that Kapa’s protein engineering technology is customizable, generates large numbers of variants and can rapidly provide enzymes with tailored performance for […]
Calendar year second quarter organic growth continued at a strong pace for major US publicly held instrument and laboratory product companies. However, currency headwinds, as well as weakness in industrial markets and Japan expunged organic growth. Currency reduced gains by about 7%, resulting in roughly flat second quarter average sales growth. Pharmaceutical and biotechnology markets […]
The US Bureau of Economic Analysis (BEA) released this month the latest figures for US companies’ R&D domestic spending and R&D spending by foreign-owned affiliates. The report shows dramatic shifts in annual R&D spending by both segments in recent years among industries that are major purchasers of analytical instruments. The data provide quantitative information on […]
The consolidation of drug distributors is resulting in mergers among manufacturers of generic drugs. In the US, four companies buy the majority of generics, and generic-drug firms could merge to increase their abilities to negotiate with distributors. Merging may also help the companies face the costs of heightened examination of the industry by US regulators […]
In 2014, the top 50 chemical companies’ sales totaled $961.3 billion, declining less than 1% from last year’s $965.1 billion. The loss was in line with falling chemical prices resulting from the drop in oil prices. In general, specialty chemical companies fared better than petrochemical firms. The combined operating income of the 44 public companies […]
Slow Growth for Bruker Despite higher-than-expected sales and sequential growth, Bruker’s Scientific Instruments (BSI) second quarter sales grew just 0.6% to $366.2 million to account for 92% of revenues (see page 12). Bruker BioSpin sales fell in the mid-single digits due to lower demand in Preclinical Imaging, which accounts for 20% of Group sales. The […]
Susteren, Netherlands 7/13/15—Research reagent firm Nordic-MUbio has acquired the antibody and protein assets of US-based Brighter Ideas for an undisclosed amount. The acquisition includes the only source of antibodies against native Aequorea victoria green fluorescent protein (GFP). “Citations of GFP remain at a very high level since it was first described in 1994 as it […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
